JNJ
JNJ 200MA TradeJNJ has bounced off the 200MA. The last two moves pushed slightly through it, hence my entry at 137 for another touch, with a stop of c.1% (135.50) below the MA and parallel channel line, and a modest target of 143, the Sep 18 high, giving a 4:1 trade.
The 2018 price/action below the MA shows this stock does take that indicator into account. Note also a fairly good match to the previous climb.
JNJ Sideways and declineJNJ debit spread 130/120 Put spread 2.53 debit Max profit is 7.47 exp September 20th.
I have a pretty long debit spread on JNJ its a high reward low risk trade.
I think it may continue lower slightly and hit my target which in this case will be $5 on the spread.
If I lose and it rises and stays above 135 etc. I will close the trade on August 30th for a loss and salvage anything that I can.
This is a journal entry and not trading advice.
Double bottom breakdown and sideways movement is my prediction since we're in a bull market it may move higher.
"Joe's earning season preview" EP02 : Let's Rock'n roll!The earning season already take places!
Let's check out the major names that will have their earning report this week with me yo!
Mon: C
Tue: GS, JPM, JNJ,WFC,UAL, IBKR
Wed: ABT, BAC, NFLX
Thur: MSFT, MS, UNH
and I got only 20 minutes so I didn't record down Friday names like AXP, BLK, and SLB!
Let's see how they go this week yo!
THE WEEK AHEAD: IBM, JNJ, NFLX EARNINGS; GDXJ, GLD, SLV, GDXEARNINGS
IBM (54/26; Thursday), JNJ (56/23; Tuesday before market open), and NFLX (35/41; Wednesday after market close) announce earnings next week. Unfortunately, all of them have less than ideal metrics for a volatility contraction play (>70% rank/>50% implied), so I'm likely to pass on all of them. That being said:
Pictured here is an IBM 130/135/150/155 iron condor in the August cycle paying 1.53, break evens at 133.47/151.53, and delta/theta metrics of -2.47/2.80. The rank/implied metrics aren't ideal here (<70%/<50%), which is probably why it's also paying less than my idea one-third the width of the wings in credit. I would pass on it if you can't get filled for 1.67 or greater ... .
BROAD MARKET
TLT (31/11)
QQQ (8/17)
IWM (7/15)
SPY (6/12)
EEM (3/16)
EFA (5/10)
Short-term, broad market premium selling is about as crappy as it can get here. Your options are to (a) wait for a pop in volatility; or (b) sell something farther out in time where the expiry implied is higher. I will probably opt for the latter if we don't get an uptick in volatility by July opex, since waiting can be unproductive, particularly if low volatility has infected the entire market and it becomes a "protracted thing."
SECTOR EXCHANGE-TRADED FUNDS
Premium selling opportunities are in gold and the miners for yet another week ... .
Top 5 By Rank: GDXJ (73/34), GLD (72/15), SLV (70/20), GDX (45/28), and TLT (31/11). Metrically, the most "ideal" play is in GDXJ (exchange-traded fund ideals: >50% rank/>35% background), although we're getting somewhat short in duration for another play in the August cycle. There isn't a September expiry available yet (there will probably be one after July expires), so it might be worth a look at GDXJ next week should volatility hang in there for a September play.
IRA TRADES
Not doing a ton here beyond managing my covered calls post-opex. Stuff on my shopping list (XLU, XLP, HYG) has all ground higher along with the rest of the market, so I just have to patient for another one of those December style "sell everything" dips or a major uptick in volatility in those instruments.* Although I have "not a penny more" short puts on in HYG, both XLP and XLU are out of range of that kind of play, it seems, unless I want to go far out in time and get paid very little ... .
* -- XLU (10/14), XLP (29/11), HYG (13/6).
Shorting JNJ sharesOn the daily chart, the instrument has started a new bearish trend as the price is moving under the Alligator indicator with AO below the zero line after divergence in the correction. I expect the price to continue the downfall if we break the recently formed sell fractal. My TP and SL levels are marked on the chart.
JNJ: Stuck in a trading range, buybacks are supporting the stockA weekly chart reveals the long-term trading range in which JNJ has been stuck. This Dow component ran up due to buybacks around the start of this year. But the trend and volume-based indicators show a lack of quiet accumulation by Dark Pools. The stock slid down ahead of its earnings release today and gapped up slightly on the report, but there has been considerable profit-taking today as well. So JNJ remains bound in a narrower range just below the trading range highs, where it could languish for some time.
JNJ - Weekly Review Feb 25 - Mar 01Weekly Outlook chart is in the related ideas. JNJ ran up on the first day of the week. Couldn't hit daily profit target and sold off after hitting the upper trend line of the channel, pulled back the next couple of days and then made a move up and hit both daily and weekly profit targets before selling off and then finally on Friday it broke and closed above the targets finding resistance on the monthly resistance.
$JNJ - Weekly Outlook Feb 25 - Mar 01$JNJ is in a up trending channel and pushing against the upper trend line of the channel. I am seeing resistance area at 137.80 - 138.30. It bounced off daily support nicely and headed straight up. I feel confident it will hit the first profit target 137.80 early next week. This is where you should be taking profits if you are in JNJ. If JNJ runs next week, second profit target 139.55 is also possible.
I got into JNJ when I saw it successfully bounced off support and I will exit my position when it hits 137.80 which could be Monday or Tuesday (unless for any reason market sells off at the start of the week). For a longer-term JNJ perspective, Mar 04 looks to be the date when FDA is expected to give its approval on the JNJ's new depression drug. Once approved, JNJ can see a decent pump.
US-China trade news can make it go in either direction. Deadline of Mar 01 is next week. Next week is news critical. Markets will make moves depending on what kind of trade-related news we get.
If you would like me to analyse a stock ticker, please feel free to mention in the comments.
News article for JNJ's new depression drug: www.businessinsider.com
JNJ Closed above the 20Week Moving Average bullish RSI-LongJNJ Closed above the 20week moving average,
has a bullish RSI divergence above 50 and
has a J-hook pattern.
Immediate target is 150 area and short to intermediate
price target appears to be 162.97-167 within a parallel
channel. 02/15/2019, Moody's maintains AAA rating
with rising revenue. After many years, TALC issues
are baked in. Evidence is earnings jump, buyouts, Apple deals, New Depression drug
with major Future cash flows and new revenue streams ahead.
Latest market decline had little impact on JNJ.
The worst appears behind JNJ with growing revenues.
JNJ Approaching Support, Potential Bounce! JNJ is approaching our first support at 117.78 (horizontal overlap support, 100% fibonacci extension, 50%, 23.6% fibonacci retracement) where a strong bounce could occur above this level pushing price up to our major resistance at 136.78 (horizontal pullback resistance, 61.8% fibonacci retracement, 61.8% fibonacci extension).
Stochastic (89,5,3) is also approaching support where we might see a corresponding bounce in price.
JNJ Approaching Resistance, Potential Drop! JNJ is approaching our first resistance at 132.37 (horizontal pullback resistance, 61.8% Fibonacci extension, 23.6% Fibonacci retracement) where a strong drop might occur below this level pushing price down to our major support at 119.46 (horizontal swing low support, 100% Fibonacci extension).
RSI (89) is also seeing a bearish exit and we might see a corresponding drop in price.